Wird geladen...
A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors
The primary objective of this trial was to establish the maximum tolerated dose (MTD) of oxaliplatin 130 mg/m(2) preceded by escalating doses of docetaxel 60 mg/m(2) (75, 90, 100 mg/m(2)) administered every 3 weeks. A total of 11 patients were entered; 10 evaluable for response: 4 stable disease (li...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3779138/ https://ncbi.nlm.nih.gov/pubmed/23712328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-013-2171-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|